Future strategies in the management of dyslipidemia

被引：1

作者：

Birmohun, R. ^{[1
]}

Stroes, E. ^{[1
]}

Kastelein, J. ^{[1
]}

机构：

[1] Acad Med Ctr Amsterdam, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

来源：

FUTURE CARDIOLOGY | 2005年 / 1卷 / 02期

关键词：

ApoA-1; Milano; ApoA-1 mimetic peptides; cholesteryl ester transfer protein inhibitors; dyslipidemia; fibrates; high-density lipoprotein cholesterol; management; Niacin;

D O I：

10.1517/14796678.1.2.127

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：127 / 130

页数：4

共 20 条

[1]

[Anonymous], 1972, JAMA, V221, P918

[2] Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials [J].

Birjmohun, RS ;

Hutten, BA ;

Kastelein, JJP ;

Stroes, ESG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) :185-197

[3]

Birjmohun RS, 2004, NETH J MED, V62, P229

[4] Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study [J].

Boekholdt, SM ;

Kuivenhoven, JA ;

Wareham, NJ ;

Peters, RJG ;

Jukema, JW ;

Luben, R ;

Bingham, SA ;

Day, NE ;

Kastelein, JJP ;

Khaw, KT .

CIRCULATION, 2004, 110 (11) :1418-1423

[5] Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol [J].

Brousseau, ME ;

Schaefer, EJ ;

Wolfe, ML ;

Bloedon, LT ;

Digenio, AG ;

Clark, RW ;

Mancuso, JP ;

Rader, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1505-1515

[6]

BROWN BG, 1995, ANN NY ACAD SCI, V748, P407

[7] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[8] Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib [J].

Clark, RW ;

Sutfin, TA ;

Ruggeri, RB ;

Willauer, AT ;

Sugarman, ED ;

Magnus-Aryitey, G ;

Cosgrove, PG ;

Sand, TM ;

Wester, RT ;

Williams, JA ;

Perlman, ME ;

Bamberger, MJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :490-497

[9]

Collins R, 2003, LANCET, V361, P2005

[10] Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans - A randomized phase II dose-response study [J].

de Grooth, GJ ;

Kuivenhoven, JA ;

Stalenhoef, AFH ;

de Graaf, J ;

Zwinderman, AH ;

Posma, JL ;

van Tol, A ;

Kastelein, JJP .

CIRCULATION, 2002, 105 (18) :2159-2165

← 1 2 →